Valuation: Integra LifeSciences Holdings Corporation

Market Cap 146.18Cr 127.86Cr 117.94Cr 108.93Cr 206.69Cr 14TCr 210.16Cr 1.41TCr 553.38Cr 6.87TCr 548.86Cr 536.92Cr 24TCr P/E 2026 *
28.9x
P/E 2027 * 15.7x
Enterprise Value 280.01Cr 244.93Cr 225.92Cr 208.66Cr 395.92Cr 27TCr 402.58Cr 2.7TCr 1.06TCr 13TCr 1.05TCr 1.03TCr 45TCr EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.52x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day+2.18%
1 week+4.10%
Current month+4.62%
1 month+9.95%
3 months+89.80%
6 months+38.37%
Current year+51.29%
1 week 17.01
Extreme 17.01
18.86
1 month 17.01
Extreme 17.01
18.92
Current year 8.7
Extreme 8.7
18.92
1 year 8.7
Extreme 8.7
18.92
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
03/07Tax

Chief Financial Officer

-5,226 0.0067%
01/07Tax

Controller/Auditor

-937 0.0012%
01/07Free

Executive/Senior Manager

5,590 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+2.18%+4.10%+42.67%-53.89% 146.18Cr
-0.50%-1.54%-29.69%-12.23% 16TCr
+1.80%+0.82%-6.19%-2.98% 11TCr
+0.32%+2.34%+2.06%+57.36% 5.9TCr
+0.79%-3.68%+40.47%+55.85% 5.17TCr
+0.72%-3.88%-14.40%-41.01% 4.19TCr
+0.47%-4.98% - - 3.47TCr
+2.66%+5.21%-12.29%-42.61% 2.89TCr
-1.10%-3.29%+54.30%-6.25% 2.5TCr
0.00%-1.01%-6.38%-3.16% 2.11TCr
Average +1.00%-0.52%+7.84%-5.44% 5.35TCr
Weighted average by Cap. +1.32%-0.92%-5.96%+1.41%

Financials

2026 *2027 *
Net sales 167.61Cr 146.61Cr 135.23Cr 124.89Cr 236.98Cr 16TCr 240.97Cr 1.62TCr 634.49Cr 7.87TCr 629.31Cr 615.62Cr 27TCr 173.01Cr 151.33Cr 139.59Cr 128.92Cr 244.62Cr 17TCr 248.74Cr 1.67TCr 654.95Cr 8.13TCr 649.6Cr 635.47Cr 28TCr
Net income 4.27Cr 3.74Cr 3.45Cr 3.18Cr 6.04Cr 407.55Cr 6.14Cr 41Cr 16Cr 200.77Cr 16Cr 16Cr 690.22Cr 7.46Cr 6.52Cr 6.02Cr 5.56Cr 11Cr 711.16Cr 11Cr 72Cr 28Cr 350.34Cr 28Cr 27Cr 1.2TCr
Net Debt 133.83Cr 117.06Cr 107.98Cr 100Cr 189.23Cr 13TCr 192.41Cr 1.29TCr 506.64Cr 6.29TCr 502.51Cr 491.57Cr 22TCr 117.59Cr 102.86Cr 95Cr 88Cr 166.27Cr 11TCr 169.06Cr 1.13TCr 445.16Cr 5.53TCr 441.53Cr 431.92Cr 19TCr
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
10/26/10 $18.79 +2.18% 9,51,869
09/26/09 $18.39 +6.30% 9,39,773
08/26/08 $17.30 -0.92% 7,02,386
07/26/07 $17.46 -3.96% 11,06,193
06/26/06 $18.18 +0.72% 8,82,014
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
18.79USD
Average target price
18.00USD
Spread / Average Target
-4.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock